Home NDC 70121-1754 ALYMSYS
Product NDC 70121-1754
11-digit product format 701211754
Labeler code 70121
Product ID 70121-1754_ca8057b2-9aec-43bc-8525-cf8091433c71
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name bevacizumab-maly
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Amneal Pharmaceuticals LLC
Application BLA761231
Marketing category BLA
Marketing start 2022-04-15
Marketing end 2028-10-31
Substance BEVACIZUMAB
Active strength 100 mg/4mL
Pharmacologic classes Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
NDC exclude flag No
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 6 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…
Additional Listing Data#
Finished product Yes
Brand name base ALYMSYS Active Ingredients# Ingredient, Strength table Ingredient Strength BEVACIZUMAB 100 mg/4mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2S9ZZM9Q9V Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2599043 Internal RxNorm lookup 2599049 Internal RxNorm lookup 2599051 Internal RxNorm lookup 2599052 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70121-1754-1 ALYMSYS 4 mL in 1 VIAL INJECTION, SOLUTION 4 9 70121-1754-1 ALYMSYS 1 in 1 CARTON INJECTION, SOLUTION 1 9 70121-1754-7 ALYMSYS 4 mL in 1 VIAL INJECTION, SOLUTION 4 9 70121-1754-7 ALYMSYS 10 in 1 CARTON INJECTION, SOLUTION 10 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70121-1754 ALYMSYS (BEVACIZUMAB-MALY) INJECTION, SOLUTION [AMNEAL PHARMACEUTICALS LLC] 8 Current NDC, Legacy NDC, 4 package rows 20250302_6b4040a2-a5c5-4ff0-ab45-935d7e49cf78.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761231 Alymsys bevacizumab-maly 351(k) Biosimilar Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 70121-1754-1 70121175401 1 VIAL in 1 CARTON (70121-1754-1) / 4 mL in 1 VIAL 1 vial 2022-04-15 2028-10-31 No No Current 70121-1754-7 70121175407 10 CARTON in 1 CARTON (70121-1754-7) > 1 VIAL in 1 CARTON (70121-1754-1) > 4 mL in 1 VIAL 10 carton 2022-04-15 0000-00-00 No No Current